These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1068348)

  • 1. Leukaemia of the myeloid series in patients with Hodgkin's disease.
    Stenfert Kroese WF; Sizoo W; Somers R
    Neth J Med; 1976; 19(4-5):234-8. PubMed ID: 1068348
    [No Abstract]   [Full Text] [Related]  

  • 2. Hodgkin's disease terminating in acute myeloid leukaemia.
    Mauri C; Quaglino D
    Haematologica; 1974 Mar; 59(1):86-90. PubMed ID: 4213144
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukaemia in Hodgkin's disease.
    Falkson HC; Portugal MA; Falkson G
    S Afr Med J; 1976 Aug; 50(3F):1429-31. PubMed ID: 1067672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hodgkin's disease evolving into acute leukemia. Report of 2 cases].
    Armenta D; Pretty HM; Long LA; Neemeh JA; Gosselin G
    Union Med Can; 1975 May; 104(5):744-8. PubMed ID: 1056113
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cyclic polychemotherapy of Hodgkin's disease].
    Berényi E; Szegedi G
    Orv Hetil; 1984 Oct; 125(41):2477-81. PubMed ID: 6493760
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of polychemotherapy and its complications in late stages of Hodgkin's disease].
    Anikin BS; Kaganov AL; Tarlova RM
    Ter Arkh; 1976; 48(8):73-9. PubMed ID: 1024302
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
    Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
    Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trial treatment of acute leukemia and Hodgkin's disease with rubidomycin (or daunomycin) alone or in combination].
    Mathé G; Amiel JL; Hayat M; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Ceoara B
    Sem Hop; 1967 Jul; 43(32):2108-14. PubMed ID: 4292321
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gonadal hypotrophy and acute leukemia after chemotherapy for Hodgkin's disease. Report of a case (author's transl)].
    Lebreton C; Grange MJ; Tchernia G; Schweisguth O
    Arch Fr Pediatr; 1981 Nov; 38(9):697-9. PubMed ID: 6949500
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polychemotherapy of generalized forms of Hodgkin's disease].
    Koverzneva MM; Kondrat'eva AP; Lorie IuI
    Ter Arkh; 1976; 48(8):84-8. PubMed ID: 1024303
    [No Abstract]   [Full Text] [Related]  

  • 13. [A reserve chemotherapy for Hodgkin's disease (author's transl)].
    Amiel JL; Ayed FB; Droz JP; Tursz T; Brule CH
    Nouv Presse Med; 1980 Oct; 9(37):2705-6. PubMed ID: 6159573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
    De Lena M; Monfardini S; Beretta G; Fossati-Bellani F; Bonadonna G
    Natl Cancer Inst Monogr; 1973 May; 36():403-20. PubMed ID: 4126720
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
    Sutcliffe SB; Economopoulos T; Wrigley PF; Stansfeld AG; Malpas JS
    Clin Oncol; 1980 Dec; 6(4):329-36. PubMed ID: 6161731
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensive chemotherapy for Hodgkin's disease: long-term complications.
    DeVita VT; Arseneau JC; Sherins RJ; Canellos GP; Young RC
    Natl Cancer Inst Monogr; 1973 May; 36():447-54. PubMed ID: 4744600
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nephrotic syndrome in Hodgkin's disease].
    Capra Marzani M
    Arch Sci Med (Torino); 1981; 138(4):543-56. PubMed ID: 7041852
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute leukaemia in the course of Hodgkin's disease: report of two cases (author's transl)].
    Mitrou PS; Fischer M; Martin H
    Dtsch Med Wochenschr; 1974 Aug; 99(31):1596-7. PubMed ID: 4526423
    [No Abstract]   [Full Text] [Related]  

  • 19. [Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma].
    Schneider M; Band P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2952-4. PubMed ID: 4292621
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
    Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
    Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.